Want to see JP:3671 full AI Analyst Report?
3671 Stock Chart & Stats
¥334.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥334.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥270.00 - ¥416.00
Previous CloseN/A
Volume5.20K
Average Volume (3M)140.46K
Market Cap
¥7.94B
Enterprise Value¥6.67B
Total Cash (Recent Filing)¥2.86B
Total Debt (Recent Filing)¥2.46B
Price to Earnings (P/E)14.2
Beta0.53
Next Earnings
Aug 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.99%
Share Statistics
EPS (TTM)23.55
Shares Outstanding24,050,800
10 Day Avg. Volume144,320
30 Day Avg. Volume140,460
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)2.04
Price to Sales (P/S)1.16
P/FCF Ratio20.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthcare-focused Recurring RevenueSoftmax’s core business centers on hospital information systems and follow-on maintenance/operational support, creating sticky, long-duration customer relationships. Long implementation cycles and recurring contracts help stabilize revenue and provide predictable service income over multiple years.
Consistent Historical ProfitabilitySustained mid-single-digit net margins and low-teens EBIT indicate an established, profitable service/software model that can absorb cyclical swings. Consistent margins support reinvestment in products and service capabilities and underpin durable earnings power despite episodic revenue weakness.
High Free Cash Flow ConversionFree cash flow tracking closely with net income demonstrates earnings quality and cash realism. Strong cash conversion supports capex, dividends and debt servicing flexibility over time, providing a buffer for strategic investment or smoothing payouts during growth fluctuations.
Bears Say
Sharp 2025 Revenue DeclineA 22% revenue drop in 2025 materially weakens the growth trajectory and reduces scale benefits. Persistent revenue weakness risks lower backlog renewal, less pricing leverage and diminished ability to fund product development internally, pressuring medium-term competitiveness.
Margin Compression In 2025Notable margin deterioration signals cost or pricing pressure that erodes operating cash generation. If structural, compressed margins will reduce free cash flow and constrain reinvestment or debt reduction, making recovery slower and increasing sensitivity to future demand volatility.
Rising Leverage And Weaker Operating Cash FlowHigher debt-to-equity and a fall in operating cash flow (operating CF fell to 389M from 663M) reduce financial flexibility. Elevated leverage increases refinancing and solvency risk if earnings remain volatile, limiting the company’s ability to invest or absorb further industry headwinds.
3671 FAQ
What was Softmax Co., Ltd. (Japan)’s price range in the past 12 months?
Softmax Co., Ltd. (Japan) lowest stock price was ¥270.00 and its highest was ¥416.00 in the past 12 months.
What is Softmax Co., Ltd. (Japan)’s market cap?
Softmax Co., Ltd. (Japan)’s market cap is ¥7.94B.
When is Softmax Co., Ltd. (Japan)’s upcoming earnings report date?
Softmax Co., Ltd. (Japan)’s upcoming earnings report date is Aug 12, 2026 which is in 10 days.
How were Softmax Co., Ltd. (Japan)’s earnings last quarter?
Softmax Co., Ltd. (Japan) released its earnings results on May 12, 2026. The company reported ¥7.03 earnings per share for the quarter, beating the consensus estimate of N/A by ¥7.03.
Is Softmax Co., Ltd. (Japan) overvalued?
According to Wall Street analysts Softmax Co., Ltd. (Japan)’s price is currently Overvalued.
Does Softmax Co., Ltd. (Japan) pay dividends?
Softmax Co., Ltd. (Japan) pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.99%. See more information on Softmax Co., Ltd. (Japan) dividends here
What is Softmax Co., Ltd. (Japan)’s EPS estimate?
Softmax Co., Ltd. (Japan)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Softmax Co., Ltd. (Japan) have?
Softmax Co., Ltd. (Japan) has 24,050,800 shares outstanding.
What happened to Softmax Co., Ltd. (Japan)’s price movement after its last earnings report?
Softmax Co., Ltd. (Japan) reported an EPS of ¥7.03 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -3.779%.
Which hedge fund is a major shareholder of Softmax Co., Ltd. (Japan)?
Currently, no hedge funds are holding shares in JP:3671
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Softmax Co., Ltd. (Japan)
Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information systems. Their offerings within the healthcare sector are diverse, comprising web-based electronic medical record (EMR) systems, online patient ordering platforms, medical financial management software, radiology information systems, and specialized solutions for rehabilitation departments, health screening, nursing task management, and surgical units. Established in 1974, Softmax Co., Ltd's corporate headquarters are located in Tokyo, Japan.